CDKN2D and neoplasm: CDK4/6 activity is regulated by the INK4 family proteins (p16INK4A, p15INK4B, p18INK4C, and p19INK4D), can inhibit the expression of CDK4 and lead to cell cycle arrest in the G1/S phase, thus considered as a natural tumor inhibitor (45).